SA
Log In
ALBO
OverviewStreamNotebookIntelChart

Analyst Sentiment

Wall St. Consensus
Buy
11 analysts·Moderate coverage
66
Score
7 Buy (64%)4 Hold (36%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
764%
Hold
436%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$42.00
-4.9%
Consensus
$42.00
-4.9%
Bull
$48.00
+8.7%
12-Month Target Range11 analysts
$42.00$42.00$48.00
Current $44.15Consensus
Current Price
$44.15
Above Consensus
$2.15

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Recent Analyst Actions

Jan 11, 2023Cowen & Co.
Cowen & Co. Downgrades Albireo Pharma to Market Perform, Lowers Price Target to $48
Target:$48.00
+9.5%from $43.85
Jan 11, 2023Jefferies
Jefferies Downgrades Albireo Pharma to Hold, Lowers Price Target to $42
Target:$42.00
-4.2%from $43.85
Jan 9, 2023Wedbush
Wedbush Downgrades Albireo Pharma to Neutral, Lowers Price Target to $42
Target:$42.00
-4.4%from $43.95

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.